Avoro Capital Advisors LLC Aadi Bioscience, Inc. Transaction History
Avoro Capital Advisors LLC
- $8.3 Billion
- Q1 2024
A detailed history of Avoro Capital Advisors LLC transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 2,849,402 shares of AADI stock, worth $4.16 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
2,849,402
Previous 2,849,402
-0.0%
Holding current value
$4.16 Million
Previous $5.76 Million
15.85%
% of portfolio
0.08%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding AADI
# of Institutions
64Shares Held
13.7MCall Options Held
4.9KPut Options Held
700-
Acuta Capital Partners, LLC Belmont, CA1.85MShares$2.7 Million3.54% of portfolio
-
Satter Management Co., L.P.1.63MShares$2.38 Million4.26% of portfolio
-
Black Rock Inc. New York, NY1.04MShares$1.52 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA857KShares$1.25 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny544KShares$793,8340.0% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $30.7M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...